A detailed history of Headlands Technologies LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Headlands Technologies LLC holds 54,318 shares of NEO stock, worth $561,648. This represents 0.04% of its overall portfolio holdings.

Number of Shares
54,318
Previous 4,445 1122.0%
Holding current value
$561,648
Previous $32,000 1209.38%
% of portfolio
0.04%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$4.84 - $8.81 $241,385 - $439,381
49,873 Added 1122.0%
54,318 $419,000
Q2 2025

Aug 14, 2025

BUY
$6.4 - $10.27 $28,448 - $45,650
4,445 New
4,445 $32,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.3B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.